Cargando…

Clinical laboratory reference values amongst children aged 4 weeks to 17 months in Kilifi, Kenya: A cross sectional observational study

Reference intervals for clinical laboratory parameters are important for assessing eligibility, toxicity grading and management of adverse events in clinical trials. Nonetheless, haematological and biochemical parameters used for clinical trials in sub-Saharan Africa are typically derived from indus...

Descripción completa

Detalles Bibliográficos
Autores principales: Gitaka, Jesse, Ogwang, Caroline, Ngari, Moses, Akoo, Pauline, Olotu, Ally, Kerubo, Christine, Fegan, Greg, Njuguna, Patricia, Nyakaya, Godfrey, Otieno, Tuda, Mwambingu, Gabriel, Awuondo, Ken, Lowe, Brett, Chilengi, Roma, Berkley, James A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5426761/
https://www.ncbi.nlm.nih.gov/pubmed/28493930
http://dx.doi.org/10.1371/journal.pone.0177382
_version_ 1783235547423047680
author Gitaka, Jesse
Ogwang, Caroline
Ngari, Moses
Akoo, Pauline
Olotu, Ally
Kerubo, Christine
Fegan, Greg
Njuguna, Patricia
Nyakaya, Godfrey
Otieno, Tuda
Mwambingu, Gabriel
Awuondo, Ken
Lowe, Brett
Chilengi, Roma
Berkley, James A.
author_facet Gitaka, Jesse
Ogwang, Caroline
Ngari, Moses
Akoo, Pauline
Olotu, Ally
Kerubo, Christine
Fegan, Greg
Njuguna, Patricia
Nyakaya, Godfrey
Otieno, Tuda
Mwambingu, Gabriel
Awuondo, Ken
Lowe, Brett
Chilengi, Roma
Berkley, James A.
author_sort Gitaka, Jesse
collection PubMed
description Reference intervals for clinical laboratory parameters are important for assessing eligibility, toxicity grading and management of adverse events in clinical trials. Nonetheless, haematological and biochemical parameters used for clinical trials in sub-Saharan Africa are typically derived from industrialized countries, or from WHO references that are not region-specific. We set out to establish community reference values for haematological and biochemical parameters amongst children aged 4 weeks to 17 months in Kilifi, Kenya. We conducted a cross sectional study nested within phase II and III trials of RTS, S malaria vaccine candidate. We analysed 10 haematological and 2 biochemical parameters from 1,070 and 423 community children without illness prior to experimental vaccine administration. Statistical analysis followed Clinical and Laboratory Standards Institute EP28-A3c guidelines. 95% reference ranges and their respective 90% confidence intervals were determined using non-parametric methods. Findings were compared with published ranges from Tanzania, Europe and The United States. We determined the reference ranges within the following age partitions: 4 weeks to <6 months, 6 months to less than <12 months, and 12 months to 17 months for the haematological parameters; and 4 weeks to 17 months for the biochemical parameters. There were no gender differences for all haematological and biochemical parameters in all age groups. Hb, MCV and platelets 95% reference ranges in infants largely overlapped with those from United States or Europe, except for the lower limit for Hb, Hct and platelets (lower); and upper limit for platelets (higher) and haematocrit(lower). Community norms for common haematological and biochemical parameters differ from developed countries. This reaffirms the need in clinical trials for locally derived reference values to detect deviation from what is usual in typical children in low and middle income countries.
format Online
Article
Text
id pubmed-5426761
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-54267612017-05-25 Clinical laboratory reference values amongst children aged 4 weeks to 17 months in Kilifi, Kenya: A cross sectional observational study Gitaka, Jesse Ogwang, Caroline Ngari, Moses Akoo, Pauline Olotu, Ally Kerubo, Christine Fegan, Greg Njuguna, Patricia Nyakaya, Godfrey Otieno, Tuda Mwambingu, Gabriel Awuondo, Ken Lowe, Brett Chilengi, Roma Berkley, James A. PLoS One Research Article Reference intervals for clinical laboratory parameters are important for assessing eligibility, toxicity grading and management of adverse events in clinical trials. Nonetheless, haematological and biochemical parameters used for clinical trials in sub-Saharan Africa are typically derived from industrialized countries, or from WHO references that are not region-specific. We set out to establish community reference values for haematological and biochemical parameters amongst children aged 4 weeks to 17 months in Kilifi, Kenya. We conducted a cross sectional study nested within phase II and III trials of RTS, S malaria vaccine candidate. We analysed 10 haematological and 2 biochemical parameters from 1,070 and 423 community children without illness prior to experimental vaccine administration. Statistical analysis followed Clinical and Laboratory Standards Institute EP28-A3c guidelines. 95% reference ranges and their respective 90% confidence intervals were determined using non-parametric methods. Findings were compared with published ranges from Tanzania, Europe and The United States. We determined the reference ranges within the following age partitions: 4 weeks to <6 months, 6 months to less than <12 months, and 12 months to 17 months for the haematological parameters; and 4 weeks to 17 months for the biochemical parameters. There were no gender differences for all haematological and biochemical parameters in all age groups. Hb, MCV and platelets 95% reference ranges in infants largely overlapped with those from United States or Europe, except for the lower limit for Hb, Hct and platelets (lower); and upper limit for platelets (higher) and haematocrit(lower). Community norms for common haematological and biochemical parameters differ from developed countries. This reaffirms the need in clinical trials for locally derived reference values to detect deviation from what is usual in typical children in low and middle income countries. Public Library of Science 2017-05-11 /pmc/articles/PMC5426761/ /pubmed/28493930 http://dx.doi.org/10.1371/journal.pone.0177382 Text en © 2017 Gitaka et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Gitaka, Jesse
Ogwang, Caroline
Ngari, Moses
Akoo, Pauline
Olotu, Ally
Kerubo, Christine
Fegan, Greg
Njuguna, Patricia
Nyakaya, Godfrey
Otieno, Tuda
Mwambingu, Gabriel
Awuondo, Ken
Lowe, Brett
Chilengi, Roma
Berkley, James A.
Clinical laboratory reference values amongst children aged 4 weeks to 17 months in Kilifi, Kenya: A cross sectional observational study
title Clinical laboratory reference values amongst children aged 4 weeks to 17 months in Kilifi, Kenya: A cross sectional observational study
title_full Clinical laboratory reference values amongst children aged 4 weeks to 17 months in Kilifi, Kenya: A cross sectional observational study
title_fullStr Clinical laboratory reference values amongst children aged 4 weeks to 17 months in Kilifi, Kenya: A cross sectional observational study
title_full_unstemmed Clinical laboratory reference values amongst children aged 4 weeks to 17 months in Kilifi, Kenya: A cross sectional observational study
title_short Clinical laboratory reference values amongst children aged 4 weeks to 17 months in Kilifi, Kenya: A cross sectional observational study
title_sort clinical laboratory reference values amongst children aged 4 weeks to 17 months in kilifi, kenya: a cross sectional observational study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5426761/
https://www.ncbi.nlm.nih.gov/pubmed/28493930
http://dx.doi.org/10.1371/journal.pone.0177382
work_keys_str_mv AT gitakajesse clinicallaboratoryreferencevaluesamongstchildrenaged4weeksto17monthsinkilifikenyaacrosssectionalobservationalstudy
AT ogwangcaroline clinicallaboratoryreferencevaluesamongstchildrenaged4weeksto17monthsinkilifikenyaacrosssectionalobservationalstudy
AT ngarimoses clinicallaboratoryreferencevaluesamongstchildrenaged4weeksto17monthsinkilifikenyaacrosssectionalobservationalstudy
AT akoopauline clinicallaboratoryreferencevaluesamongstchildrenaged4weeksto17monthsinkilifikenyaacrosssectionalobservationalstudy
AT olotually clinicallaboratoryreferencevaluesamongstchildrenaged4weeksto17monthsinkilifikenyaacrosssectionalobservationalstudy
AT kerubochristine clinicallaboratoryreferencevaluesamongstchildrenaged4weeksto17monthsinkilifikenyaacrosssectionalobservationalstudy
AT fegangreg clinicallaboratoryreferencevaluesamongstchildrenaged4weeksto17monthsinkilifikenyaacrosssectionalobservationalstudy
AT njugunapatricia clinicallaboratoryreferencevaluesamongstchildrenaged4weeksto17monthsinkilifikenyaacrosssectionalobservationalstudy
AT nyakayagodfrey clinicallaboratoryreferencevaluesamongstchildrenaged4weeksto17monthsinkilifikenyaacrosssectionalobservationalstudy
AT otienotuda clinicallaboratoryreferencevaluesamongstchildrenaged4weeksto17monthsinkilifikenyaacrosssectionalobservationalstudy
AT mwambingugabriel clinicallaboratoryreferencevaluesamongstchildrenaged4weeksto17monthsinkilifikenyaacrosssectionalobservationalstudy
AT awuondoken clinicallaboratoryreferencevaluesamongstchildrenaged4weeksto17monthsinkilifikenyaacrosssectionalobservationalstudy
AT lowebrett clinicallaboratoryreferencevaluesamongstchildrenaged4weeksto17monthsinkilifikenyaacrosssectionalobservationalstudy
AT chilengiroma clinicallaboratoryreferencevaluesamongstchildrenaged4weeksto17monthsinkilifikenyaacrosssectionalobservationalstudy
AT berkleyjamesa clinicallaboratoryreferencevaluesamongstchildrenaged4weeksto17monthsinkilifikenyaacrosssectionalobservationalstudy